Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations for over 10 years. Sora Lee, general manager of Syneos Korea, provides her assessment of the impact of the merger. She also comments on Syneos Health’s MoU with KoNECT (Korea National Enterprise for Clinical Trials) to foster clinical research in Korea and offers her opinion on the ease of patient enrollment for CROs operating in South Korea.
Having successfully grown over the past decade, we now employ around 180 people at the Korean office and have conducted over 140 studies since 2013
